Analysis of differential lipofection efficiency in primary and established myoblasts
- PMID: 11829523
- DOI: 10.1006/mthe.2002.0528
Analysis of differential lipofection efficiency in primary and established myoblasts
Abstract
In this study we have compared the process of lipid-mediated transfection in primary and established myoblasts, in an attempt to elucidate the mechanisms responsible for the scarce transfectability of the former. We determined the metabolic stability of cytoplasmically injected and lipofected DNA in primary and established myoblasts and carried out a comparative time course analysis of luciferase reporter-gene expression and DNA stability. The efficiency of the transcription-translation machinery of the two cell types was compared by intranuclear injection of naked plasmid DNA encoding luciferase. Subcellular colocalization of fluorescein-labeled lipopolyplexes with specific endosomal and lysosomal markers was performed by confocal microscopy to monitor the intracellular trafficking of plasmid DNA during transfection. The metabolic stability of plasmid DNA was similar in primary and established myoblasts after both lipofection and cytoplasmic injection. In both cell types, lipofection had no detectable effect on the rate of cell proliferation. Confocal analysis showed that nuclear translocation of transfected DNA coincided with localization in a compartment devoid of endosome- or lysosome-specific marker proteins. The residency time of plasmid DNA in this compartment differed for primary and established myoblasts. Our findings suggest that the lower transfectability of primary myoblasts is mostly due to a difference in the intracellular delivery pathway that correlates with more rapid delivery of internalized complex to the lysosomal compartment.
Similar articles
-
Adenovirus-assisted lipofection: efficient in vitro gene transfer of luciferase and cytosine deaminase to human smooth muscle cells.Atherosclerosis. 1996 Jul;124(1):49-60. doi: 10.1016/0021-9150(96)05816-9. Atherosclerosis. 1996. PMID: 8800493
-
Adenovirus or HA-2 fusogenic peptide-assisted lipofection increases cytoplasmic levels of plasmid in nondividing endothelium with little enhancement of transgene expression.J Gene Med. 2002 Jan-Feb;4(1):75-83. doi: 10.1002/jgm.235. J Gene Med. 2002. PMID: 11828390
-
Electrotransfection and lipofection show comparable efficiency for in vitro gene delivery of primary human myoblasts.J Membr Biol. 2015 Apr;248(2):273-83. doi: 10.1007/s00232-014-9766-5. Epub 2014 Dec 23. J Membr Biol. 2015. PMID: 25534347
-
Vascular applications of human gene therapy.Semin Interv Cardiol. 1996 Mar;1(1):84-8. Semin Interv Cardiol. 1996. PMID: 9552498 Review.
-
Non-viral gene delivery in skeletal muscle: a protein factory.Gene Ther. 2003 Jan;10(2):131-42. doi: 10.1038/sj.gt.3301874. Gene Ther. 2003. PMID: 12571642 Review.
Cited by
-
New-Generation Benzimidazole-Based Plasmid Delivery Reagents with High Transfection Efficiencies on the Mammalian Cells.In Vitro Cell Dev Biol Anim. 2020 Jan;56(1):34-41. doi: 10.1007/s11626-019-00418-4. Epub 2020 Jan 2. In Vitro Cell Dev Biol Anim. 2020. PMID: 31898010
-
Polylysine for skin regeneration: A review of recent advances and future perspectives.Bioeng Transl Med. 2021 Nov 5;7(1):e10261. doi: 10.1002/btm2.10261. eCollection 2022 Jan. Bioeng Transl Med. 2021. PMID: 35111953 Free PMC article. Review.
-
Polyplex-induced cytosolic nuclease activation leads to differential transgene expression.Mol Pharm. 2013 Aug 5;10(8):3013-22. doi: 10.1021/mp400103f. Epub 2013 Jul 24. Mol Pharm. 2013. PMID: 23834286 Free PMC article.
-
Inhibition of monocyte chemoattractant protein-1 prevents diaphragmatic inflammation and maintains contractile function during endotoxemia.Crit Care. 2010;14(5):R187. doi: 10.1186/cc9295. Epub 2010 Oct 7. Crit Care. 2010. PMID: 20950459 Free PMC article.
-
Transfection of normal primary human skeletal myoblasts with p21 and p57 antisense oligonucleotides to improve their proliferation: a first step towards an alternative molecular therapy approach of Duchenne muscular dystrophy.J Mol Med (Berl). 2003 Jun;81(6):355-62. doi: 10.1007/s00109-003-0439-6. Epub 2003 May 6. J Mol Med (Berl). 2003. PMID: 12732930
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources